Factors associated with long-term survival in gemcitabine-concurrent proton radiotherapy for non-metastatic locally advanced pancreatic cancer: a single-center retrospective study

Radiation Oncology

Masaki Suga¹  Nor Shazrina Sulaiman²  Yoshiro Matsuo²  Sunao Tokumaru²  Kazuki Terashima²  Tomoaki Okimoto²  SungChul Park²  Daiki Takahashi²  Hirochika Toyama³  Takumi Fukumoto³  Yoshihide Nanno³  Yuta Ogura⁴ 

[1] Department of Radiation Physics, Hyogo Ion Bseam Medical Center, 1-2-1 Kouto, Shingu-cho, 679-5165, Tatsuno, Hyogo, Japan;Department of Radiology, Hyogo Ion Beam Medical Center, 1-2-1 Kouto, Shingu-cho, 679-5165, Tatsuno, Hyogo, Japan;Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, 650-0017, Kobe, Hyogo, Japan;Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, 650-0017, Kobe, Hyogo, Japan;Department of Radiology, Hyogo Ion Beam Medical Center, 1-2-1 Kouto, Shingu-cho, 679-5165, Tatsuno, Hyogo, Japan;

关键词: Pancreatic cancer;    Proton radiotherapy;    Gemcitabine;    Chemoradiotherapy;    Retrospective study;    Prognostic factor;    Long-term survival outcome;   

DOI  :  10.1186/s13014-022-02001-w

来源: Springer

【 授权许可】

CC BY